Codes / ICD10CM / T39.396D

T39.396D Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
  • Technical term: T39.396D

Summary

Underdosing of other nonsteroidal anti-inflammatory drugs (NSAIDs) during a subsequent encounter occurs when a patient takes lower than the prescribed amount of these medications, leading to inadequate pain or inflammation control. This may result in persistent symptoms or progression of the underlying condition for which the NSAID was prescribed.

Causes

Underdosing can stem from patient misunderstanding of dosage instructions, intentional dose reduction due to concerns about side effects, or inadequate counseling by healthcare providers. It may also occur if the patient experiences absorption issues or fails to adhere to the prescribed regimen.

Risk Factors

  • Older adults with cognitive difficulties or memory impairment.
  • Patients with a history of non-adherence to medication regimens.
  • Those with anxiety about potential NSAID side effects.
  • Individuals with limited health literacy or language barriers.

Symptoms

  • Persistent or worsening pain and inflammation.
  • Ineffective management of the condition for which the NSAID was prescribed.
  • Possible recurrence or progression of the original medical issue.

Diagnosis

Diagnosis involves reviewing the patient’s medication history, including dosing adherence and refill patterns. Patient interviews assess symptom control and understanding of instructions. Healthcare providers may also evaluate for underlying factors contributing to underdosing, such as absorption issues or non-adherence.

Treatment Options

  • Adjusting the NSAID dosage to the appropriate therapeutic level.
  • Educating patients on the importance of taking medications as prescribed.
  • Addressing patient concerns about side effects to improve adherence.
  • Monitoring for signs of inadequate therapeutic response.

Prognosis and Follow-Up

With proper dosage adjustment and patient education, outcomes typically improve. Follow-up may include regular assessments of symptom control and adherence. Persistent underdosing may require further intervention to address underlying barriers to compliance.

Complications

  • Worsening of the condition requiring the NSAID (e.g., arthritis, injury).
  • Increased risk of additional treatments or interventions.
  • Potential for delayed recovery or prolonged discomfort.

Lifestyle & Prevention

  • Clearly communicate dosage instructions and potential side effects to patients.
  • Use pill organizers or reminders to support adherence.
  • Encourage patients to report concerns about medication use promptly.
  • Regularly review medication regimens to ensure appropriateness.

When to Seek Professional Help

Seek medical attention if symptoms persist despite dosage adjustments or if new symptoms develop. Contact a healthcare provider if there are concerns about medication adherence or side effects.

Tips for Medical Coders

Document the encounter type (subsequent) and any factors contributing to underdosing, such as patient education provided or adherence issues. Ensure the code aligns with the clinical scenario and encounter timing.

Book a walkthrough

T39.396D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.